Nicousamide

硝克柳胺

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameNicousamide
Drug Alias NameNicosamideXLF-III-43
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTransforming growth factor beta 1 inhibitors
TargetsTransforming growth factor beta 1
Therapy Area/IndicationsHypertensive nephropathyDiabetic Nephropathies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesInstitue Of Materia Medica Chinese Academy Of Medical Science
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesInstitue Of Materia Medica Chinese Academy Of Medical ScienceJiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsHypertensive nephropathyDiabetic Nephropathies
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksDrugBank